Parkside Financial Bank & Trust Purchases 1,005 Shares of Cigna Group $CI

Parkside Financial Bank & Trust increased its holdings in shares of Cigna Group (NYSE:CI) by 40.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,510 shares of the health services provider’s stock after purchasing an additional 1,005 shares during the period. Parkside Financial Bank & Trust’s holdings in Cigna Group were worth $1,160,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Flaharty Asset Management LLC bought a new stake in shares of Cigna Group in the 1st quarter valued at $28,000. 1248 Management LLC bought a new position in Cigna Group during the first quarter worth $29,000. Solstein Capital LLC acquired a new stake in Cigna Group in the second quarter worth $29,000. Activest Wealth Management grew its stake in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after buying an additional 72 shares during the period. Finally, Chilton Capital Management LLC bought a new position in Cigna Group in the second quarter worth approximately $30,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Price Performance

Shares of NYSE:CI opened at $264.54 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company’s 50-day moving average is $293.24 and its 200 day moving average is $303.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market capitalization of $70.66 billion, a P/E ratio of 14.44, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the previous year, the company earned $7.51 earnings per share. The company’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is currently 26.64%.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CI has been the subject of several recent research reports. The Goldman Sachs Group decreased their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday. Zacks Research downgraded shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Cowen reissued a “buy” rating on shares of Cigna Group in a research report on Tuesday. Wolfe Research decreased their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Finally, Leerink Partners lowered their price objective on Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $344.91.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.